AI assistant
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2020
Oct 8, 2020
33148_dirs_2020-10-07_1e714b65-c3c8-4d64-b95e-90ad4f6d0632.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2020-10-05
Reporting Person: Patel Kinnari (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-10-05 | Restricted Stock Units | $ | A | 10000 | Acquired | 2030-10-05 | Common Stock (10000) | Indirect |
Footnotes
F1: Each restricted stock unit represents a right to receive one share of RCKT common stock upon satisfaction of vesting conditions.
F2: The restricted stock units were issued pursuant to the Rocket Pharmaceuticals Inc. 2014 Stock Option and Incentive Plan. The restricted stock units shall vest in equal annual installments over 3 years from October 5, 2020 (date of grant) subject to continued service through such dates.
F3: The restricted stock units were granted to the reporting person's husband, in connection with a Consulting Agreement for information technology services provided to the Company.